Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (21 quarters reported)
$178M in Q4 2020 → $2.03M now. Hover for any quarter.
As reported for the quarter ended December 31, 2025. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Compass Pathways PLC | 94.8% | Unchanged | 278,880 | $1.92M |
| R Rumble Inc | 5.2% | Unchanged | 16,564 | $105K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended December 31, 2025 · filed February 17, 2026
No position changes this quarter.
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| R Rumble Inc | New | +16,564 | +$120K | 7.0% |
quarter ended June 30, 2025 · filed August 14, 2025
No position changes this quarter.
quarter ended March 31, 2025 · filed May 15, 2025
No position changes this quarter.
quarter ended December 31, 2024 · filed February 14, 2025
No position changes this quarter.
quarter ended September 30, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Abcellera Biologics Inc | Exited | −3,773,530 | −$11.2M | — |
quarter ended June 30, 2024 · filed August 14, 2024
No position changes this quarter.
quarter ended March 31, 2024 · filed May 15, 2024
No position changes this quarter.
Loading...
